CN Patent

CN116829148A — 治疗囊性纤维化的方法

Assigned to Vertex Pharmaceuticals Inc · Expires 2023-09-29 · 3y expired

What this patent protects

本申请描述了治疗囊性纤维化或CFTR介导的疾病的方法，所述方法包括施用化合物I或其药学上可接受的盐。本申请还描述了包括化合物I或其药学上可接受的盐并且任选地包括一种或多种另外的CFTR调节剂的药物组合物。

USPTO Abstract

本申请描述了治疗囊性纤维化或CFTR介导的疾病的方法，所述方法包括施用化合物I或其药学上可接受的盐。本申请还描述了包括化合物I或其药学上可接受的盐并且任选地包括一种或多种另外的CFTR调节剂的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN116829148A
Jurisdiction: CN
Classification: —
Expires: 2023-09-29
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.